Melissa McBurnie - Profile and Investment Details

Investor Profile

Melissa McBurnie is a Venture Capital, Investor, Private Equity Firm based in Adelaide, South Australia, Australia with a diverse investment portfolio that includes companies such as QUE Oncology, Elastagen, Denteric, MecRx, Spinifex Pharmaceuticals, Heart Metabolics, PolyActiva, Cardiora, Q-Sera, Okogen, Ena Respiratory, G I Therapies, Protego Medical, Vaxxas, Myricx Pharma, Signostics, EBR Systems, Auspherix, Solvanix, MetaBloQ, OccuRx, Global Kinetics Corporation, Aravax, Fibrotech Therapeutics. Over time, Melissa McBurnie has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Melissa McBurnie is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Health Care, Medical Testing, Life Science, Biotech, Medical Device, Healthcare, Biotechnology, Health and Hospital Services, Neuroscience, Financial Services, Health Diagnostics, Medical, Therapeutics, Media and Entertainment, Pharmaceuticals, Biopharma may find it worthwhile to explore potential connections with Melissa McBurnie, as their portfolio suggests a familiarity and interest in this area.

Understanding Melissa McBurnie’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.